These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33453064)

  • 1. Oxidative degradation profile studies of tavaborole by a validated stability indicating RP-UPLC method: Isolation and characterization of novel degradant using 2D-NMR and HRMS.
    Puppala U; Marisetti VM; Srinivas KSV; Reddy KV; Kaliyaperumal M; Doddipalla R
    Biomed Chromatogr; 2021 Jun; 35(6):e5070. PubMed ID: 33453064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversed-phase liquid chromatography with electrospray mass detection and 1H and 13C NMR characterization of new process-related impurities, including forced degradants of efavirenz: related substances correlated to the synthetic pathway.
    Gadapayale K; Kakde R; Sarma VU
    J Sep Sci; 2015 Jan; 38(2):218-30. PubMed ID: 25385054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of Prothionamide degradation impurities by mass spectrometry, NMR spectroscopy, and ultra high performance liquid chromatography method development.
    Baksam VK; Saritha N; Mohan SK; Shandilya S; Kumar P
    J Sep Sci; 2021 May; 44(10):2078-2088. PubMed ID: 33733566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validated stability-indicating liquid chromatographic method for the determination of retapamulin in topical dosage form.
    Nalwade S; Reddy VR
    J Chromatogr Sci; 2014 Mar; 52(3):238-45. PubMed ID: 23510782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RP-HPLC stability-indicating assay method for talinolol and characterization of its degradation products.
    Sinha VR; Ghai D
    J Chromatogr Sci; 2011; 49(10):786-95. PubMed ID: 22080807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of a Stability-Indicating RP-UPLC Method for Determination of Cloxacillin Sodium in Its Bulk Form and Formulation.
    Patel N; Contractor P; Keshrala R; Patel PR; Shridhar B
    J Chromatogr Sci; 2015 Jul; 53(6):903-8. PubMed ID: 25368408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
    Lalitha Devi M; Chandrasekhar KB
    J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical method development and validation for the analysis of verapamil hydrochloride and its related substances by using ultra perfomance liquid chromatography.
    Vijayabaskar S; Mahalingam V; Kalaivani
    J Pharm Biomed Anal; 2017 Apr; 137():189-195. PubMed ID: 28131058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
    Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
    J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability-Indicating RP-HPLC Method for the Estimation of Process-Related Impurities and Degradation Products in Fesoterodine Fumarate by Using a Mass Spectrometric Compatible Mobile Phase.
    Kumar N; Sangeetha D; Kalyanraman L
    J Chromatogr Sci; 2021 Jan; 59(2):154-164. PubMed ID: 33190158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel reverse phase stability indicating RP-UPLC method for the quantitative determination of fifteen related substances in Ranolazine drug substance and drug product.
    Malati V; Reddy AR; Mukkanti K; Suryanarayana MV
    Talanta; 2012 Aug; 97():563-73. PubMed ID: 22841123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impurity profiling and a stability-indicating UPLC method development and validation for the estimation of related impurities of halobetasol propionate in halobetasol propionate 0.05% (w/w) cream.
    Prakash L; Malipeddi H; Subbaiah BV; Lakka NS
    J Chromatogr Sci; 2015 Jan; 53(1):112-21. PubMed ID: 24795078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability Indicating RP-HPLC Method for Estimation of Potential Impurities in Ledipasvir and Characterization of a New Degradation Impurity.
    Siva Kumar R; Sravan Kumar KV; Kondareddy L; Yogeshwara KR; Manish G; Jeenet J; Nitesh K
    J Chromatogr Sci; 2018 May; 56(5):383-395. PubMed ID: 29474520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC-ESI-QTOF-MS analysis utilizing gas-phase fragmentation reactions subjected to ESI-IS-CID and ESI-CID-MS/MS conditions to study the degradation behaviour of sorafenib tosylate: NMR and in vitro cytotoxicity and apoptosis detection studies of hydrolytic degradation products.
    Johnsirani P; Wani AA; Bharatam PV; Nanjappan S
    J Pharm Biomed Anal; 2020 Jan; 177():112881. PubMed ID: 31542419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a simple method for the extraction and quantification of crisaborole in skin layers.
    Demurtas A; Pescina S; Nicoli S; Santi P; Padula C
    Biomed Chromatogr; 2019 Nov; 33(11):e4664. PubMed ID: 31342550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification, isolation and characterization of dolutegravir forced degradation products and their cytotoxicity potential.
    Saida SJ; Manikandan A; Kaliyaperumal M; Rumalla CS; Khan AA; Jayaraman VB; Yanaka R; Venkat Rao S
    J Pharm Biomed Anal; 2019 Sep; 174():588-594. PubMed ID: 31261040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Force degradation behavior of glucocorticoid deflazacort by UPLC: isolation, identification and characterization of degradant by FTIR, NMR and mass analysis.
    Deshmukh R; Sharma L; Tekade M; Kesharwani P; Trivedi P; Tekade RK
    J Biomed Res; 2016 Mar; 30(2):149-161. PubMed ID: 28276670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forced degradation of nepafenac: Development and validation of stability indicating UHPLC method.
    Runje M; Babić S; Meštrović E; Nekola I; Dujmić-Vučinić Ž; Vojčić N
    J Pharm Biomed Anal; 2016 May; 123():42-52. PubMed ID: 26871279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of RP UPLC-TOF/MS, stability indicating method for omeprazole and its related substances by applying two level factorial design; and identification and synthesis of non-pharmacopoeial impurities.
    Jadhav SB; Kumar CK; Bandichhor R; Bhosale PN
    J Pharm Biomed Anal; 2016 Jan; 118():370-379. PubMed ID: 26600119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation studies of pentoxifylline: Isolation and characterization of a novel gem-dihydroperoxide derivative as major oxidative degradation product.
    Mone MK; Chandrasekhar KB
    J Pharm Biomed Anal; 2010 Nov; 53(3):335-42. PubMed ID: 20466503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.